Full Text View
Tabular View
No Study Results Posted
Related Studies
An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections
This study has been completed.
Study NCT00092170   Information provided by Merck

First Received on September 21, 2004.   Last Updated on October 8, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Infections
Pelvic Infections
Additional conditions recognized in this trial
Pelvic Infection
Pelvic Inflammatory Disease
More general conditions related to this trial
Adnexal Diseases
Genital Diseases, Female
Infection
Interventions listed in this trial
MK0826, ertapenem sodium
Comparator: Ticarcillin/Clavulanate
Additional drug interventions recognized in this trial
Clavulanic Acid
Clavulanic Acids
Ertapenem
Ticarcillin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services